FDA maintained its position that CBD in any ingestible form is subject to the drug preclusion language in the federal Food Drug and Cosmetic Act via refusal letters posted regarding New Dietary Ingredient Notifications (NDIN) filed by Charlotte’s Web and
Continue Reading FDA Rejects CBD New Dietary Ingredient Notifications: Four Practical Takeaways
CBD and Hemp Legal and Regulatory Roundup – August 6, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
CBD
Radicle Science study will evaluate effectiveness of various CBD products
Radicle Science, a healthtech B-corp that validates natural products, launched the Radicle ACES (Advancing CBD Education
Continue Reading CBD and Hemp Legal and Regulatory Roundup – August 6, 2021
CBD and Hemp Legal and Regulatory Roundup – July 30, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
CBD
CBA calls for clear federal regulations relation to OTC sales of CBD products
In a letter to the acting commissioner of the FDA, the Consumer Brands
Continue Reading CBD and Hemp Legal and Regulatory Roundup – July 30, 2021
CBD and Hemp Legal and Regulatory Roundup – July 23, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
CBD
Iowa Court of Appeals upholds state’s view of CBD as controlled substance
The Iowa Appeals Court sided with the Marion Civil Service Commission, saying Sarah Hyatt
Continue Reading CBD and Hemp Legal and Regulatory Roundup – July 23, 2021
CBD and Hemp Legal and Regulatory Roundup – July 16, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
CBD
Report: CBD beverages market to pass $14B before end of 2026
According to a Facts & Factors report, the CBD infused beverages market, valued at
Continue Reading CBD and Hemp Legal and Regulatory Roundup – July 16, 2021
CBD and Hemp Legal and Regulatory Roundup – July 2, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
CBD
Congressional report offers overview of CBD/hemp market, policy challenges
The Congressional Research Service (CRS) released a report which says there are “three leading markets for hemp,
Continue Reading CBD and Hemp Legal and Regulatory Roundup – July 2, 2021
CBD and Hemp Legal and Regulatory Roundup – June 25, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
CBD
Judge tosses $9M CBD oil suit saying Ky. is wrong venue
U.S. District Judge Robert E. Wier tossed a hemp farm’s $9-million contract dispute suit against
Continue Reading CBD and Hemp Legal and Regulatory Roundup – June 25, 2021
CBD and Hemp Legal and Regulatory Roundup – June 11, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
CBD
Medterra CBD seeks sanctions against Healthcare Resources Management Group over ‘frivolous’ claims
A Calif.-based hemp products merchant renewed its push for sanctions against a Fla. company
Continue Reading CBD and Hemp Legal and Regulatory Roundup – June 11, 2021
CBD and Hemp Legal and Regulatory Roundup – June 4, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
CBD
Charlotte’s Web wants CBD products label class paused pending legislation
Charlotte’s Web told a federal judge that Rasunae Moqeet’s proposed class action over the company’s product
Continue Reading CBD and Hemp Legal and Regulatory Roundup – June 4, 2021
CBD and Hemp Legal and Regulatory Roundup – May 28, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
CBD
U.S. lawmakers propose updating CBD regulations
Under the Hemp Access and Consumer Safety Act introduced by Sens. Ron Wyden (D-Ore.), Jeff Merkley (D-Ore.) and Rand Paul
Continue Reading CBD and Hemp Legal and Regulatory Roundup – May 28, 2021